Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IBIT vs MRNA✓SelectedUSD · MRNAIBIT vs MRNA performance historyLatest closeAs of-0.79%11/19
Stock and ETF performance explorer

IBIT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-30.8%
MRNA return
+698.9%
Excess return
-729.8%
Maximum drawdown
-40.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.8%+1.3%-2.1%-0.9%
7D-13.1%-13.8%+0.8%-12.4%
30D-24.9%-17.7%-7.2%-24.2%
3M-9.5%+14.3%-23.8%-10.5%
6M-19.4%+336.0%-355.3%-32.2%
YTD-29.3%+575.9%-605.3%-45.4%
1Y-30.8%+724.4%-755.2%-48.4%
All-30.8%+698.9%-729.8%-48.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling